HLTW:PA:PA-Multi Units Luxembourg - Lyxor MSCI World Health Care TR UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 502

Change

+1.86 (+0.37)%

Market Cap

USD 0.75B

Volume

603.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Sub-Fund is an index-tracking UCITS passively managed. The Reference Currency of the Sub-Fund is the Euro (EUR). The investment objective of sub-fund is to track both the upward and the downward evolution of the MSCI World Health Care Index " Net Total Return (the Index) denominated in US Dollars - while minimising the volatility of the difference between the return of the Sub-Fund and the return of the Index (the "Tracking Error"). The anticipated level of the tracking error under normal market conditions is expected to be up to 0.50%.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.22 (-0.46%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.70 (-0.12%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.21 (+0.05%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.04 (+0.10%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.54 (+0.60%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.43 (+0.12%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.06 (-0.10%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.22 (+0.14%)

USD 5.17B

ETFs Containing HLTW:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.09% 66% D+ 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.09% 65% D 62% D
Trailing 12 Months  
Capital Gain 4.25% 25% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.25% 21% F 46% F
Trailing 5 Years  
Capital Gain 44.17% 59% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.17% 56% F 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.33% 59% D- 64% D
Dividend Return 10.33% 58% F 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.81% 69% C- 90% A-
Risk Adjusted Return 117.23% 91% A- 97% N/A
Market Capitalization 0.75B 74% C 75% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike